HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

5- propylamino- 5,6- dihydro- 4H- imidazo(4,5,1- ij)quinolin- 2(1H)- one

an imidazoquinolinone dopamine D2 agonist; structure given in first source

Also Known As:

U 91356; U 91356A; U-91356; U-91356A; U91356A

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - 5-propylamino-5,6-dihydro-4H-imidazo(4,5,1-ij)quinolin-2(1H)-one: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - Aminoquinolines: 29
        5-propylamino-5,6-dihydro-4H-imidazo(4,5,1-ij)quinolin-2(1H)-one: 2

Related Diseases

1.

Dyskinesias (Dyskinesia)

10/03/1997 - "In contrast, U91356A given in a continuous mode led to partial behavioral tolerance without appearance of dyskinesias. "
05/22/1995 - "In contrast, animals treated in a continuous mode with U91356A showed behavioral tolerance but did not develop dyskinesia. "
05/22/1995 - "Animals treated in a pulsatile mode with U91356A or levodopa injections showed progressive sensitization to their respective drug and developed choreic dyskinesia. "
10/03/1997 - "In MPTP monkeys, pulsatile treatment with either L-DOPA or U91356A relieved parkinsonian symptoms but caused progressive sensitization to treatment and, as expected, induced choreic dyskinesias. "

Related Drugs and Biologics

1.	Levodopa (L Dopa)
2.	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)

Related Therapies and Procedures

1.	Injections